Scilex Holding Company announced the publication of a study in Pain Medicine News revealing that patients treated with ZTlido® (lidocaine topical system 1.8%) showed a greater reduction in opioid use ...
Scilex (SCLX) announced that Pain Medicine News published retrospective claims data on ZTlido vs. lidocaine 5% patch. Pain Medicine News, the premier trade publication in the pain management space, ...
More patients treated with ZTlido ® saw either a decrease or discontinuation of opioid use compared with those treated with the 5% patch (51.9% vs. 45.5%). Of all study patients reporting a decrease ...
Mylan Pharmaceuticals (Nasdaq: MYL) has won a potential $121.5 million contract from the Defense Logistics Agency to provide lidocaine 5 percent patch, a medicine designed for the treatment of ...
Please provide your email address to receive an email when new articles are posted on . The FDA has issued warnings to six companies for the marketing of analgesics with unlawful lidocaine ...
Aveva Drug Delivery Systems has received permission from the Food and Drug Administration for its generic lidocaine 1.8% patch, a non-opioid topical treatment for post-herpetic neuralgia. The generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results